Publication

Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: Initial safety and pharmacokinetic results from the PALOMA study

Krebs, Matthew G
; 
Johnson, M. L.
; 
Cho, B. C.
; 
Lee, S. H.
; 
Kudgus-Lokken, R.
; 
Zemlickis, D.
; 
Mitselos, A.
; 
Berkay, E.
; 
Bauml, J. M.
; 
Knoblauch, R. E.
... show 2 more
Citations
Altmetric:
Abstract
Authors
Krebs, Matthew G
Johnson, M. L.
Cho, B. C.
Lee, S. H.
Kudgus-Lokken, R.
Zemlickis, D.
Mitselos, A.
Berkay, E.
Bauml, J. M.
Knoblauch, R. E.
Hellemans, P.
Minchom, A.
Affiliation
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester,
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Krebs MG, Johnson ML, Cho BC, Lee SH, Kudgus-Lokken R, Zemlickis D, et al. Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: Initial safety and pharmacokinetic results from the PALOMA study. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509502113.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/626262
Embedded videos